As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.
7 Analysts have issued a NEMAURA MEDICAL INC forecast:
7 Analysts have issued a NEMAURA MEDICAL INC forecast:
Dec '23 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -9.46 -9.46 |
60%
60%
|
EBIT (Operating Income) EBIT | -9.94 -9.94 |
58%
58%
|
Net Profit | -11 -11 |
19%
19%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. The sugarBEAT is consist of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in Loughborough, the United Kingdom.
Head office | United States |
CEO | Dewan Chowdhury |
Employees | 36 |
Founded | 2013 |
Website | nemauramedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.